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Under conditions of the open field test, 30 control Wistar rats and 30 rats with experimental 
cardiomyopathy (CMP) were examined with recording of four behavioral indices, (i) number of crossed 
squares (intensity of locomotion), (ii) number of rearings (vertical stands), (iii) number of examined 
holes in the arena, and (iv) number of grooming episodes, within a 28-day-long observation period. The 
CMP state was induced by five i.p. injections of 5.0 mg/kg of doxorubicin with one-week-long intervals. 
As was found, all behavioral indices of control rats demonstrated considerable (sometime statistically 
significant) variations within the observation period (this fact has probably attracted insufficient attention 
in analogous experiments with long-lasting observation periods). The development of doxorubicin-
induced CMP resulted in considerable suppression of all types of behavioral activity, relatively 
moderate within the first week of observation and dramatic within late phases of the observation period. 
The dynamics of the numbers of rearings and grooming phenomena were complex, with noticeable 
increases on days 3 and 14. The dynamics of the numbers of rearings and inspection of the holes in both 
experimental groups were significantly dissimilar, which indicates that these behavioral phenomena are 
related to different aspects of the research/orientatinal activity. In general, a state of increased anxiety 
followed by the development of a depression-like state was observed in CMP rats. These negative shifts 
in behavioral activity are believed to result from general CMP-induced insufficiency of blood supply 
of the brain and development of hypoxia in the latter; specific direct effects of doxorubicin on some 
cerebral structures seem to be unlikely. 
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INTRODUCTION
Heart diseases are the main cause of mortality in 
people of mature age [1]. Cardiovascular pathologies 
are frequently accompanied by cognitive disorders, 
neurotic states, psychopathies, and personality 
disorders [2, 3]. Such disorders, in turn, worsen the 
prognosis of the underlying disease and, in many 
cases, lead to the disability of cardiological patients 
[1]. 
Disorders in CNS functioning resulting from 
cardiovascular pathologies have, in general, 
insufficiently been studied at present. This problem 
was subjected to intense investigations during 
many years, but a number of its aspects have still 
not been sufficiently interpreted; this is why the 
respective studies remain at present highly urgent 
[4]. Investigations within this field made necessary 
the development of adequate animal models of 
cardiomyopathy (CMP). Among most extensively 
used models of this pathology, there is doxorubicin-
induced CMP. As was found, the antibiotic 
doxorubicin, in the case of its course introduction, 
evokes intense side effects manifested as strong 
pathological changes in the myocardium. The 
technique of induction of experimental doxorubicin-
induced CMP has been developed in detail on rats 
[5]; the mechanisms of pathogenesis and functional 
disorders developing under such conditions 
demonstrate significant similarity to those in 
humans [6]. As is believed, the main link of the 
pathogenesis of cognitive disorders against the CMP 
background are negative changes in blood supply of 
the brain resulting in the development of circulatory 
hypoxia [7]. Some researchers, however, supposed 
that behavioral and cognitive disorders at CMP are 
related to some direct action of doxorubicin inducing 
specific structural/functional shifts in the cerebral 
structures responsible for learning, motor activity, 
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and spatial orientation [8]. This is why obtaining 
of new information on behavioral modifications 
under conditions of CMP is obviously urgent. At 
present, the situation related to this problem is 
somewhat paradoxical. The pathophysiological 
and biochemical changes induced by doxorubicin 
in the organism of experimental animals have 
been studied by a number of authors, and the 
respective information is, from many aspects, 
relatively detailed. At the same time, behavioral 
manifestations that accompany experimental CMP 
were examined only in a few studies. This is why 
we subjected control rats and those suffering from 
experimental doxorubicin-induced CMP to testing 
under open field conditions. 
METHODS
The experiments were carried out on 60 albino 
male Wistar rats (age 5 to 7 months, body mass 
180–220 g). We took into account that these animals 
are most suitable for reproduction of the model 
of doxorubicin-induced CMP, and the technique 
of modeling has been developed in most detail 
precisely on rats [5]. The development of CMP in 
rats is relatively rapid and demonstrates sufficient 
similarity to that in humans [6]. Complications of 
CMP looking as functional disorders in the CNS are 
based on the same pathogenetic links as those in 
humans [6].
All animals were divided into two equal groups 
(n = 30 in each). Rats of the first control group were 
i.p. injected with 0.9% physiological saline. Animals 
of the experimental (CMP) group were also i.p. 
injected with 5.0 mg/kg body mass of Doxorubicin 
Pharmachemie B. V. (TEVA Pharmaceutical 
Industries, Netherlands/Israel). Such injections were 
performed five times with one-week-long intervals. 
Examinations of the behavioral indices in the 
CMP group were performed on days 1, 3, 7, 14, 21, 
and 28 after the last doxorubicin injection. Rats of 
the control group were examined synchronously. 
Selection of the terms of examination was related to 
periodization of the development of morphological 
and functional changes in the myocardium; the 
symptomatology of the respective disorders 
corresponded to that described earlier [9]. 
A nearly standard method of observation in the 
open field was used. The dimensions of the open 
field arena were 100 cm × 100 cm; the walls were 
40 cm high. The set was made from wood and 
painted with a stable paint. The arena was divided 
into 25 equal 20 × 20 cm squares.  On crossings 
of the borders of each square, there were openings 
(diameter 10 mm).  Spontaneous individual 
behavioral activity in the open field was recorded 
within a 3-min-long observation interval. For each 
animal, we calculated (i) total number of crossed 
squares, (ii) number of raisings of the animal on its 
hindlimbs (vertical stands), (iii) number of inspected 
holes in the arena, and (iv) that of the grooming 
episodes [10, 11]. Crossing of the square was taken 
into account when all four limbs crossed the square 
borders. Rearings (vertical stands) were taken into 
account when those were performed both with 
leaning on the wall and without such support. In the 
calculations, both short and long-lasting episodes of 
grooming were taken into account. 
Statistical treating of numerical results of 
observations was performed using STATISTICA 
v. 6.1 software (StatSoft Inc., U.S.A.; license 
No. AGAR909E415822FA). Means, s.d., and s.e.m. 
values were calculated. For intergroup comparisons, 
the Student’s t- and Mann–Whitney U-criteria 
were used. Both natural values of the indices in 
both groups and normalized values (%) for the 
experimental (CMP) group were taken into account 
(see below). 
The relations between the variables and the 
factors affecting them were estimated by calculation 
of the coefficient of canonic correlation, RC, for the 
dependence between subsets of the data in general 
within all stages of observation. Results were 
considered statistically significant at P < 0.05. 
RESULTS
Before injections of doxorubicin in the CMP 
group, testing of rats of both CMP and contrl 
groups demonstrated that there were no significant 
intergroup differences in the behavioral indices 
shown in the open field. 
The first fact that has attracted our special 
attention when analyzing the results of tests in 
the open field was that values of the measured 
behavioral indices in the control group were found 
to be noticeably unstable within the 28-day-long 
observation period. All four analyzed indices 
demonstrated clear dynamics, and the latter were 
rather specific for each behavioral manifestation. 
